Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background Fibroblast growth factor 23 (FGF23), parathyroid hormone (PTH), and phosphorus all have been proposed as plasma biomarkers for the development of coronary heart disease (CHD) in individuals with normal renal function. Methods In a nested case-control study of men in the Health Professionals Follow-up Study free of diagnosed cardiovascular disease at blood draw, we prospectively examined associations between plasma FGF23, PTH, and phosphorus and risk of coronary heart disease (CHD). During 10 years of follow-up, 422 men developed nonfatal myocardial infarction or fatal CHD. Controls were selected in a 2:1 ratio and matched for age, date of blood collection, and smoking status. Results Mean estimated glomerular filtration rate was 86 mL/min per 1.73 m2 in cases and controls. At baseline, there were no statistically significant differences between cases and controls in plasma levels of FGF23, PTH, or phosphorus. After adjusting for matching factors, family history of myocardial infarction, body mass index, alcohol consumption, physical activity, history of diabetes mellitus and hypertension, ethnicity, region, plasma 25-hydroxyvitamin D and other factors, the odds ratios for incident CHD for participants in the highest compared to lowest quartiles were 1.03 (95% CI 0.70-1.52; P for trend 0.84) for FGF23, 1.20 (95% CI 0.82-1.76; P trend 0.99) for PTH, and 0.72 (95% CI 0.51-1.02; P trend 0.13) for phosphorus. Conclusions Plasma FGF23, PTH, and phosphorus are not associated with the development of incident CHD in men without chronic kidney disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rimm, E. B., Giovannucci, E. L., Stampfer, M. J., Colditz, G. A., Litin, L. B., & Willett, W. C. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116211 · Cited by 2,104
Self-citationValidity of Self-Reported Waist and Hip Circumferences in Men and Women
Rimm, E. B., Stampfer, M. J., Colditz, G. A., Chute, C. G., Litin, L. B., & Willett, W. C. (1990) · Epidemiology · doi:10.1097/00001648-199011000-00009 · Cited by 1,015
Self-citationDhingra, R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.879 · Cited by 861
Physical Activity and Television Watching in Relation to Risk for Type 2 Diabetes Mellitus in Men
Hu, F. B., Leitzmann, M. F., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Rimm, E. B. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.12.1542 · Cited by 828
Self-citationThe Assessment of Alcohol Consumption by a Simple Self-administered Questionnaire
Glovannucci, E., Colditz, G., Stampfer, M. J., Rimm, E. B., Litin, L., Sampson, L., & Willett, W. C. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115960 · Cited by 637
Self-citationChasan-Taber, S., Rimm, E. B., Stampfer, M. J., Spiegelman, D., Colditz, G. A., Giovannucci, E., Ascherio, A., & Willett, W. C. (1996) · Epidemiology · doi:10.1097/00001648-199601000-00014 · Cited by 508
Self-citationPlasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community
Hagström, E., Hellman, P., Larsson, T. E., Ingelsson, E., Berglund, L., Sundström, J., Melhus, H., Held, C., Lind, L., Michaëlsson, K., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.808733 · Cited by 416
Cited by
Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
Scialla, J. J., Xie, H., Rahman, M., Anderson, A. H., Isakova, T., Ojo, A., Zhang, X., Nessel, L., Hamano, T., Grunwald, J. E., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050465 · Cited by 445
Update on fibroblast growth factor 23 in chronic kidney disease
Wolf, M. (2012) · Kidney International · doi:10.1038/ki.2012.176 · Cited by 391
Ix, J. H., Katz, R., Kestenbaum, B. R., de Boer, I. H., Chonchol, M., Mukamal, K. J., Rifkin, D., Siscovick, D. S., Sarnak, M. J., & Shlipak, M. G. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.040 · Cited by 324
Fibroblast Growth Factor 23 and Risk of Incident Stroke in Community-Living Adults
Panwar, B., Jenny, N. S., Howard, V. J., Wadley, V. G., Muntner, P., Kissela, B. M., Judd, S. E., & Gutiérrez, O. M. (2015) · Stroke · doi:10.1161/strokeaha.114.007489 · Cited by 65
Serum Parathyroid Hormone in Relation to All-Cause and Cardiovascular Mortality: The Hoorn Study
van Ballegooijen, A. J., Reinders, I., Visser, M., Dekker, J. M., Nijpels, G., Stehouwer, C. D. A., Pilz, S., & Brouwer, I. A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4007 · Cited by 62
Metadata
- Authors
- Taylor, E. N., Rimm, E. B., Stampfer, M. J., & Curhan, G. C.
- Venue
- American Heart Journal
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 161
- Issue
- 5
- Pages
- 956-962
- ISSN
- 0002-8703 (ISSN-L)
- OpenAlex
- W2051186854
- Cited by
- 102
- References
- 7
- FWCI
- 12.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease. https://app.cochat.ai/papers/10.1016/j.ahj.2011.02.012
- The paper
- Taylor, E. N., Rimm, E. B., Stampfer, M. J., & Curhan, G. C. (2011). Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease. American Heart Journal. https://doi.org/10.1016/j.ahj.2011.02.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.